2025
SJR Q2
JCR Q3 · 2,1
OA
10 matched articles
SCIE
Journal detail
Trials
- Publisher
- BioMed Central Ltd
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
17456215
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,892
- Quartile Q2
- H-Index 111
- Cites/doc 2,04
- Docs (3y) 2.653
- Cites (3y) 5.980
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,1
- 5Y JIF 2,3
- JCI 0,51
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Medicine (miscellaneous) Q2
- Pharmacology (medical) Q2
Areas
- Medicine
WoS categories
- Medicine, Research & Experimental
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,892 | 2,1 | 2,3 | 0,51 | Q3 | 111 |
| 2024 | Q2 | Q3 | 0,893 | 2 | 2,2 | 0,52 | Q3 | 103 |
| 2023 | Q2 | Q3 | 0,812 | 2 | 2,1 | 0,5 | Q3 | 103 |
| 2022 | Q2 | Q3 | 0,814 | 2,5 | 2,5 | 0,51 | Q3 | 103 |
| 2021 | Q1 | Q4 | 0,865 | 2,7 | 2,8 | 0,55 | Q3 | 103 |
| 2020 | Q1 | Q4 | 1,067 | 2,3 | 2,6 | 0,61 | Q3 | 103 |
| 2019 | Q1 | Q3 | 0,98 | 1,9 | 2,2 | 0,69 | Q3 | 103 |
| 2018 | — | Q3 | — | 2 | 2,3 | 0,74 | Q2 | — |
| 2017 | Q1 | Q3 | 1,291 | 2,1 | 2,3 | 0,78 | Q2 | 103 |
| 2016 | Q1 | Q3 | 1,24 | 2 | 2,2 | — | — | 103 |
| 2015 | Q1 | Q3 | 1,235 | 1,9 | 2,2 | — | — | 103 |
| 2014 | Q1 | Q3 | 1,117 | 1,7 | 2,2 | — | — | 103 |
| 2013 | Q1 | Q3 | 1,316 | 2,1 | 2,4 | — | — | 103 |
| 2012 | Q1 | Q3 | 1,483 | 2,2 | 2,6 | — | — | 103 |
| 2011 | Q1 | Q2 | 1,178 | 2,5 | 2,6 | — | — | 103 |
| 2010 | Q1 | Q2 | 1,25 | 2,1 | 2,3 | — | — | 103 |
| 2009 | — | Q3 | — | 2 | 2 | — | — | — |
| 2008 | — | Q3 | — | 1,7 | 1,7 | — | — | — |
| 2007 | — | Q3 | — | 1,4 | 1,4 | — | — | — |
| 2006 | — | — | — | — | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q3 | 121/191 |
| 2024 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q3 | 125/195 |
| 2023 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q3 | 122/189 |
| 2022 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q3 | 99/136 |
| 2021 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q3 | 106/139 |
| 2020 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q3 | 108/140 |
| 2019 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q3 | 102/139 |
| 2018 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 91/136 |
| 2017 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 83/133 |
| 2016 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 78/128 |
| 2015 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 80/124 |
| 2014 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 81/123 |
| 2013 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 63/124 |
| 2012 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 63/121 |
| 2011 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 49/112 |
| 2010 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 51/106 |
| 2009 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 47/93 |
| 2008 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 51/83 |
| 2007 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 52/81 |
| 2006 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | — | — | — |